Skip to playerSkip to main content
  • 6 years ago
GlaxoSmithKline Pharmaceuticals has decided to suspend sale of drug ranitidine or Zinetac which is used to reduce stomach acid to all countries including India. The stock remained under pressure on the back of this news in yesterday's session.
Comments

Recommended